Titanium vs. PEEK Fusion Devices in 1 Level TLIF
Launched by TWIN CITIES SPINE CENTER · Jan 18, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying two different types of devices used in spine surgery, specifically during a procedure called a one-level TLIF (Transforaminal Lumbar Interbody Fusion). The trial aims to compare titanium devices and PEEK (a type of plastic) devices to see which one works better for patients with conditions like lumbar stenosis (narrowing of the spine) and spondylolisthesis (slipped vertebra). The goal is to follow patients for two years after their surgery to assess how well they recover and how their spines heal.
To join this study, participants need to be between 18 and 70 years old and have tried at least six weeks of non-surgical treatments without success. It’s important to note that individuals who have had previous spine surgery, are undergoing more than one level of surgery, or have certain medical conditions like infections or tumors, won't be eligible to participate. If you decide to join, you can expect regular check-ups to monitor your recovery and see how well the surgery is helping your symptoms over time. This trial is not yet recruiting, so there’s more information to come if you or someone you know is interested.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. Patients undergoing 1 level TLIF for the treatment of lumbar stenosis and spondylolisthesis who have failed at least 6 weeks of non-operative treatment.
- • 2. Patients between 18-70 years of age at the time of surgery.
- • Exclusion Criteria
- • 1. Patients under 18 or over 70 years of age at the time of surgery.
- • 2. Patients undergoing more than 1 level of surgery.
- • 3. Patients who have had prior lumbar fusion.
- • 4. Patients requiring surgery for the management of infection, tumor, or trauma.
- • 5. Patients who are pregnant.
About Twin Cities Spine Center
Twin Cities Spine Center is a leading clinical trial sponsor dedicated to advancing spinal health through innovative research and development. With a strong focus on improving patient outcomes, the center conducts rigorously designed clinical trials that evaluate the efficacy and safety of cutting-edge treatments and technologies for spinal conditions. Committed to excellence in patient care and scientific integrity, Twin Cities Spine Center collaborates with a network of healthcare professionals and institutions to ensure high standards in research practices while prioritizing the well-being of participants. Through their efforts, the center aims to contribute meaningful advancements in the field of spine care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials